Metabolism-Based Identification of a Potent Thrombin Receptor Antagonist

Citations Over TimeTop 22% of 2006 papers

Abstract

The metabolism of our prototypical thrombin receptor antagonist 1, Ki = 2.7 nM, was studied and three major metabolites (2, 4, and 5) were found. The structures of the metabolites were verified independently by synthesis. Compound 4 was shown to be a potent antagonist of the thrombin receptor with a Ki = 11 nM. Additionally, compound 4 showed a 3-fold improvement in potency with respect to 1 in an agonist-induced ex-vivo platelet aggregation assay in cynomolgus monkeys after oral administration; this activity was sustained with 60% inhibition observed at 24 h post-dose. Compound 4 was highly active in functional assays and showed excellent oral bioavailability in rats and monkeys. Compound 4 showed a superior rat enzyme induction profile relative to compound 1, allowing it to replace compound 1 as a development candidate.

Related Papers

• → Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.(1992)148 cited
• → Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells(1996)38 cited
• → Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure(1995)53 cited
• → "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.(1992)53 cited
• → Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor(1991)37 cited